COMMUNIQUÉS West-GlobeNewswire

Origin(TM) Announces Positive Interim Results from Phase IIb Dose-Ranging Study for Diabetic Foot Ulcers

26/10/2017 - 14:30

Interim results demonstrate strong evidence of healing and favorable safety profile Highest-performing arm (4X per week, 12 minutes): · 95% mean wound-size reduction in 12 weeks · 71% of wounds achieved complete healing [...]

Inivata Announces World-Leading Scientific Advisory Board

26/10/2017 - 13:00

Inivata Announces World-Leading Scientific Advisory Board Research Triangle Park, NC and Cambridge, UK, 26 October2017 -- Inivata , a global clinical cancer genomics company utilizing an industry-leading liquid biopsy [...]

Apricus Biosciences Announces Corporate Update and Third Quarter 2017 Financial Results Conference Call

26/10/2017 - 13:00

SAN DIEGO, Oct. 26, 2017 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that Apricus' third quarter [...]

Abiomed Announces Q2 FY 2018 Revenue of $132.8 Million, Up 29% and Record U.S. Patient Utilization, Up 33%

26/10/2017 - 13:00

DANVERS, Mass., Oct. 26, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today reported second quarter fiscal 2018 revenue of $132.8 million, an [...]

Amer Sports to start repurchases of own shares

26/10/2017 - 13:00

Amer Sports Corporation STOCK EXCHANGE RELEASE October 26, 2017 at 2:00 p.m. Amer Sports to start repurchases of own shares Amer Sports Board of Directors has decided to utilize the authorization given by the Annual [...]

Saniona AB: Saniona decides to perform interim analysis of Tesomet study in patients with Prader-Willi syndrome

26/10/2017 - 12:45

PRESS RELEASE October 26, 2017 Saniona, a leading biotech company in the field of ion channels, today announces that nine out of a planned ten adult patients with Prader-Willi syndrome have completed or discontinued [...]

RECORDATI: VERY GOOD RESULTS IN THE FIRST NINE MONTHS 2017. CONTINUED GROWTH IN SALES +11.8%, OPERATING INCOME +21.8%, NET INCOME +20.6%. INTERIM DIVIDEND € 0.42 (+20%)

26/10/2017 - 12:01

Consolidated revenues € 963.8 million, +11.8%. EBITDA (1) € 342.0 million, +22.1% Operating income € 307.5 million, +21.8%. Net income € 219.8 million, +20.6%. Net financial position (2) : net debt of € 321.7 million. [...]

Amer Sports Corporation Interim Report January-September 2017

26/10/2017 - 12:00

Amer Sports Corporation INTERIM REPORT October 26, 2017 at 1:00 p.m. Amer Sports Corporation Interim Report January-September 2017 JULY-SEPTEMBER 2017 Net sales EUR 733.2 million (July-September 2016: 736.8). In local [...]

Orion Group Interim Report January-September 2017

26/10/2017 - 11:00

ORION CORPORATION INTERIM REPORT JANUARY-SEPTEMBER 2017 26 OCTOBER 2017 AT 12.00 NOON EEST Orion Group Interim Report January-September 2017 Orion's net sales in January-September 2017 totalled EUR 804 million (EUR 794 [...]

Shire Receives European Approval for Label Extension of FIRAZYR® (icatibant injection) for the Symptomatic Treatment of Acute HAE Attacks in Paediatric Patients

26/10/2017 - 08:00

Shire Receives European Approval for Label Extension of FIRAZYR ® (icatibant injection) for the Symptomatic Treatment of Acute Hereditary Angioedema (HAE) Attacks in Paediatric Patients FIRAZYR is the first and only [...]

Communiqué : Essilor lance une augmentation de capital réservée aux salariés du groupe situés hors de France

26/10/2017 - 07:50

Essilor lance une augmentation de capital réservée aux salariés du groupe situés hors de France Version PDF du communiqué Charenton-le-Pont, France (le 26 octobre 2017 - 8h00) - Essilor International SA annonce une [...]

News Release: Capital Increase Reserved for employees outside France

26/10/2017 - 07:50

Capital Increase Reserved for employees outside France PDF Version of the news release Charenton-le-Pont, France (October 26, 2017 - 8:00 a.m.) - Essilor International SA announces a capital increase reserved for [...]

argenx reports third quarter 2017 financial results and provides business update

26/10/2017 - 07:00

October 26, 2017 Breda, the Netherlands / Ghent, Belgium argenx (Euronext Brussels & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for [...]

MedDay Sponsors Satellite Symposium Today and Presents Additional Data on MD1003 in Progressive Multiple Sclerosis at ECTRIMS-ACTRIMS Meeting

26/10/2017 - 07:00

MedDay Sponsors Satellite Symposium Today and Presents Additional Data on MD1003 in Progressive Multiple Sclerosis at ECTRIMS-ACTRIMS Meeting MedDay is exhibiting at Booth D30 during the meeting Paris, France, 26 [...]

MedDay annonce un symposium satellite et présente des données supplémentaires sur le MD1003 dans la sclérose en plaques progressive lors du congrès ECTRIMS-ACTRIMS

26/10/2017 - 07:00

MedDay annonce un symposium satellite et présente des données supplémentaires sur le MD1003 dans la sclérose en plaques progressive lors du congrès ECTRIMS-ACTRIMS Présence de MedDay au stand D30 lors du congrès Paris, [...]

Probiodrug to Present Data from its Phase 2a SAPHIR Study at International Alzheimer's Disease Conference

26/10/2017 - 07:00

Probiodrug to Present Data from its Phase 2a SAPHIR Study at International Alzheimer's Disease Conference Prof. Philipp Scheltens, Principal Investigator of the study, to present at Clinical Trials on Alzheimer's [...]

ZAGENO on Growth Trajectory - Startup Becoming #1 Online Marketplace for Life Science Research Products; Raises $8 Million

25/10/2017 - 21:40

BOSTON, Mass., USA, and BERLIN, GERMANY, Oct. 25, 2017 (GLOBE NEWSWIRE) -- ZAGENO Inc. , announces successful Series A investment of $8 Million US Dollars led by Capnamic Ventures , with Grazia Equity , lead investor in [...]

NOTICE IN RELATION TO THE CONVERTIBLE BONDS DUE MAY 2020

25/10/2017 - 18:40

REGULATED INFORMATION GHENT, Belgium, 25 October 2017 (6.30 pm CEST) - Ablynx NV [Euronext Brussels: ABLX, NASDAQ: ABLX] , a late-stage clinical biopharmaceutical company utilising its proprietary Nanobody® platform to [...]

Enzymatica AB: Bulletin from extraordinary general meeting in Enzymatica AB (publ)

25/10/2017 - 18:00

Enzymatica Bulletin from EGM Oct 25 2017 This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients. The issuer of this announcement warrants that they are solely [...]